Supreme Court Keeps Mail Delivery of Abortion Pill Mifepristone in Place

The Supreme Court issued a ruling on Thursday that preserves the ability to ship the abortion medication mifepristone through the postal service.

The decision leaves in place the existing safety requirements for the drug, meaning pharmacies and clinics can continue to rely on mail delivery while ongoing legal challenges proceed.

The court’s order does not represent a final resolution of the broader litigation over the pill’s distribution, but it temporarily maintains the status quo for patients and providers.